IFP Exclusive

Nano Pharmaceutical Developed to Target Cancer Cells

An Iranian knowledge-based company has managed to develop a nano-pharmaceutical that targets cancerous cells and helps treat recurrent cancers.

Drugs used to treat cancer are mainly divided into biological and chemical ones. In the biological treatment, which is a common cancer treatment, cancerous tissue is targeted. However, by using nanotechnology, the nano-particles take responsibility for transporting albumin into the cancerous cell.

This increases the quality, the speed of drug distribution, and the effectiveness of the medicine. This system is especially effective for the cancers that have undergone a course of treatment and are recurrent.

Nanodarou Company was founded with a small investment as a knowledge-based firm by the students and professors of Tehran University of Medical Sciences in 2011, when the Resistance Economy was introduced and recommended by the Leader of Iran’s Islamic Revolution.

The difficulty was that no imported or domestic samples of this drug were available. Despite many complications, the drug entered the market in 2016. Within three months, it was also sold in Turkey. It is now known to be the definitive medication for recurrent cancer. The production of these drugs requires a safe environment for the workers which is provided by the company.

It is currently used to treat metastatic breast cancer, pancreatic cancer, lung cancer, ovarian cancer and stomach cancer. The main purpose of producing these drugs is to increase the patient’s life and improve his/her quality of life during the course of treatment. It means that despite the illness, there is no pain in these diseases, and the patient can have normal life.

For a brief review of Iran’s achievements in various fields of science and technology, check the book “Science and Technology in Iran: A Brief Review

Another product of this company is the addiction treatment drug that is produced by macrospheric technique (spherical particles) and injected deep into the body of the patient and continuously released in a patient’s body within a month.

In this way, the need for the opiate disappears and the receptors of pleasure fail, and ultimately it is fully treated between 6 and 24 months.

In the past year, 8,000 doses of these drugs have been consumed; and about half of them have been sold in Turkish markets.

These medications are currently exported to five countries of the world, and nine other countries will receive them as soon as possible.

The Nanodarou Company will be present at the 2018 International Nanotechnology Exhibition, which will be held from October 13 to 16 in the Iranian capital Tehran.

Seyedeh Maryam Hosseini Lahijani

Hedieh Lahiji is an Iranian journalist who mainly reports the latest developments in science and technology. Her work in the IFP is mainly focused on the coverage of Iranian knowledge-based companies and their scientific achievements.

Recent Posts

Senior advisor to Iran FM: No immediate plans to adjust military advisors in Syria

Ali Asghar Khaji, a Senior Advisor to Iran’s Foreign Minister, stated in an interview with…

2 hours ago

Biden, Xi to discuss China’s support for Russia at APEC summit

US President Joe Biden will meet with Chinese President Xi Jinping on the sidelines of…

4 hours ago

Rights group accuses Israel of crimes against humanity over forced displacement of Gazans

Israel is using evacuation orders to pursue the “deliberate and massive forced displacement” of Palestinian…

4 hours ago

Iran to give ‘immediate response’ to any anti-Tehran resolution by IAEA: Nuclear chief

Mohammad Eslami, the head of the Atomic Energy Organization of Iran (AEOI), has warned of…

4 hours ago

Trump seeking to bring Ukraine, Russia to negotiating table: US National security advisor nominee

Donald Trump wants to bring Moscow and Kyiv to the negotiating table to end the…

4 hours ago

Army commander: Iran to deliver crushing response to Israel

The Commander-in-Chief of the Iranian Army, Major General Seyyed Abdolrahim Mousavi, has vowed a decisive…

5 hours ago